Post-Approval Impact of Generic Fluticasone Propionate & Salmeterol Inhalation Powder (RLD: Advair Diskus)

Browse Research Outcomes

Author/sClerman, Andrew
Date:09/14/2023
Meeting Name:Small Business and Industry Assistance (SBIA) – Advancing Generic Drug Development: Translating Science to Approval
State:
City:Virtual